Urist Marshall (CIK 0001838139)

Latest company ownership

RPRX - Royalty Pharma plc

Role: EVP, Research & Investments

Shares held

269,569

Last filed at

Dec 3, 2025

Confidence Score

12.5

2025Q4

Confidence Score History

2021Q2 2025Q4

Recent buy/sell transactions

Exec date	Filing date	Company	Role	Signal	Confidence	Shares	% of shares	Under plan?	Amount (USD)
Dec 19, 2025	Dec 22, 2025	Royalty Pharma plc	EVP, Research & Investments	Sell	25.0	-20,000	-12.02%	✓	$767.6K
Dec 16, 2025	Dec 17, 2025	Royalty Pharma plc	EVP, Research & Investments	Sell	22.5	-20,000	-10.73%	✓	$766.4K
Dec 5, 2025	Dec 9, 2025	Royalty Pharma plc	EVP, Research & Investments	Sell	15.0	-41,576	-18.24%	✓	$1.6M
Dec 1, 2025	Dec 3, 2025	Royalty Pharma plc	EVP, Research & Investments	Sell	15.0	-41,575	-15.42%	✓	$1.7M
Feb 22, 2023	Feb 24, 2023	Royalty Pharma plc	EVP, Research & Investments	Sell	7.5	-23,333	-26.21%	✓	$870.2K
Jul 25, 2022	Jul 27, 2022	Royalty Pharma plc	EVP, Research & Investments	Sell	5.0	-23,334	-55.09%	✓	$1M
Jun 24, 2022	Jun 24, 2022	Royalty Pharma plc	EVP, Research & Investments	Sell	5.0	-23,333	-35.52%	✓	$1M
May 16, 2022	May 16, 2022	Royalty Pharma plc	EVP, Research & Investments	Sell	7.5	-23,333	-26.21%	✓	$929.8K
Jun 4, 2021	Jun 8, 2021	Royalty Pharma plc	EVP & Co-Head of R&I	Sell	5.0	-33,134	-63.53%	✓	$1.5M
Jun 2, 2021	Jun 4, 2021	Royalty Pharma plc	EVP & Co-Head Research & Inv.	Sell	12.5	-14,566	-21.83%	✓	$604.9K
May 20, 2021	May 24, 2021	Royalty Pharma plc	EVP & Co-Head Research & Inv.	Sell	41.3	-2,000	-2.91%	✓	$82.2K